Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet’s disease
Authors:
- 11 November 2008
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 72 (6) , 581-587
Abstract
Vascular endothelial growth factor (VEGF) is important for angiogenesis and inflammation, both of which are codependent and contribute to the pathophysiology of Behçet’s disease (BD). In this report, we sought to investigate whether the selected VEGF polymorphisms [−634 C/G, +936 C/T and an 18 bp insertion/deletion (I/D) at −2549 of the VEGF promoter region] are associated with susceptibility and severity of BD in the Tunisian population. One hundred and thirty‐five Tunisian BD patients and 157 healthy controls were recruited. The VEGF gene was genotyped by polymerase chain reaction followed by digestion with restriction endonucleases. VEGF serum levels of BD patients and healthy controls were measured by enzyme‐linked immunosorbent assay. We found no association between the VEGF polymorphisms and the susceptibility to BD. However, when data were analysed according to the presence of each symptom, we found a positive association between VEGF 18 bp I/D polymorphism and ocular involvement as well as BD severity. Indeed, among the BD patients, the frequency of the 18 bp I/I genotype was less in patients with ocular inflammation (6.1% vs 24.6%, P = 0.007) and in patients with severe BD (9.2% vs 21.4%, P = 0.0014). Moreover, the mean serum VEGF level was considerably higher in BD patients (P < 0.01) than in healthy controls. We suggest that VEGF gene polymorphisms may be involved in the development of the ocular BD as well as the severity of the disease.Keywords
This publication has 43 references indexed in Scilit:
- Increased Endothelin-1 Levels of BAL Fluid in Patients with Behçet's DiseaseMediators of Inflammation, 2007
- Association of Vascular Endothelial Growth Factor Gene Polymorphisms With Behcet Disease in a Korean PopulationHuman Immunology, 2005
- Behçet's diseaseBest Practice & Research Clinical Rheumatology, 2004
- 522. Increased Expression of OCT4, SOX2 and FGF4 Genes Following Injection of Embryonic Stem Cell into Damaged Murine BrainMolecular Therapy, 2004
- 523. Inhibition of Retinal Neovascularization by Intraocular Gene Delivery of Soluble VEGF ReceptorsMolecular Therapy, 2004
- New insights into the pathogenesis and therapy of Behçet's diseaseCurrent Opinion in Pharmacology, 2004
- Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and plateletsScandinavian Journal of Clinical and Laboratory Investigation, 2002
- Behçet's DiseaseNew England Journal of Medicine, 1999
- Familial aggregation in Behçet’s disease: High frequency in siblings and parents of pediatric probandsThe Journal of Pediatrics, 1999
- The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic PotencyJournal of Biological Chemistry, 1996